Lenka Jelinkova-Palova

Prague, PR, Czech Republic

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

Novel PD-1-targeted, activity-optimized IL-15 mutein SOT201 acting in cis provides antitumor activity superior to PD1-IL2v.

Novel PD-1-targeted, activity-optimized IL-15 mutein SOT201 acting in cis provides antitumor activity superior to PD1-IL2v.

Journal: Journal for immunotherapy of cancer
Published: March 26, 2025

Tissue contexture determines the pattern and density of tumor-infiltrating immune cells in HPV-associated squamous cell carcinomas of oropharynx and uterine cervix.

Tissue contexture determines the pattern and density of tumor-infiltrating immune cells in HPV-associated squamous cell carcinomas of oropharynx and uterine cervix.

Journal: Translational oncology
Published: October 02, 2023

Immunological control of ovarian carcinoma by chemotherapy and targeted anticancer agents.

Immunological control of ovarian carcinoma by chemotherapy and targeted anticancer agents.

Journal: Trends in cancer
Published: December 02, 2021

Myeloid - derived suppressor cells in Type 1 diabetes are an expanded population exhibiting diverse T-cell suppressor mechanisms.

Myeloid - derived suppressor cells in Type 1 diabetes are an expanded population exhibiting diverse T-cell suppressor mechanisms.

Journal: PloS one
Published: July 14, 2020

Methods to assess DC-dependent priming of T cell responses by dying cells.

Methods to assess DC-dependent priming of T cell responses by dying cells.

Journal: Methods in enzymology
Published: February 01, 2020

Induction of Tolerance and Immunity by Dendritic Cells: Mechanisms and Clinical Applications.

Induction of Tolerance and Immunity by Dendritic Cells: Mechanisms and Clinical Applications.

Journal: Frontiers in immunology
Published: July 18, 2019

Data on microbial DNA-induced IL-1β production in monocytes of type 1 diabetes patients.

Data on microbial DNA-induced IL-1β production in monocytes of type 1 diabetes patients.

Journal: Data in brief
Published: June 18, 2019

Monocytes contribute to DNA sensing through the TBK1 signaling pathway in type 1 diabetes patients.

Monocytes contribute to DNA sensing through the TBK1 signaling pathway in type 1 diabetes patients.

Journal: Journal of autoimmunity
Published: March 25, 2019

Optimal Tolerogenic Dendritic Cells in Type 1 Diabetes (T1D) Therapy: What Can We Learn From Non-obese Diabetic (NOD) Mouse Models?

Optimal Tolerogenic Dendritic Cells in Type 1 Diabetes (T1D) Therapy: What Can We Learn From Non-obese Diabetic (NOD) Mouse Models?

Journal: Frontiers in immunology
Published: December 21, 2018

Radiotherapy in Combination With Cytokine Treatment.

Radiotherapy in Combination With Cytokine Treatment.

Journal: Frontiers in oncology
Published: October 29, 2018

Cell Based Therapy for Type 1 Diabetes: Should We Take Hyperglycemia Into Account?

Cell Based Therapy for Type 1 Diabetes: Should We Take Hyperglycemia Into Account?

Journal: Frontiers in immunology
Published: October 25, 2018

Antigen Loading (e.g., Glutamic Acid Decarboxylase 65) of Tolerogenic DCs (tolDCs) Reduces Their Capacity to Prevent Diabetes in the Non-Obese Diabetes (NOD)-Severe Combined Immunodeficiency Model of Adoptive Cotransfer of Diabetes As Well As in NOD Mice.

Antigen Loading (e.g., Glutamic Acid Decarboxylase 65) of Tolerogenic DCs (tolDCs) Reduces Their Capacity to Prevent Diabetes in the Non-Obese Diabetes (NOD)-Severe Combined Immunodeficiency Model of Adoptive Cotransfer of Diabetes As Well As in NOD Mice.

Journal: Frontiers in immunology
Published: November 17, 2017
Showing 1-12 of 18

Last Updated: 09/26/2026